These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18405840)

  • 41. Pharmacokinetic parameter prediction from drug structure using artificial neural networks.
    Turner JV; Maddalena DJ; Cutler DJ
    Int J Pharm; 2004 Feb; 270(1-2):209-19. PubMed ID: 14726136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do Fukui function maxima relate to sites of metabolism? A critical case study.
    Beck ME
    J Chem Inf Model; 2005; 45(2):273-82. PubMed ID: 15807488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular imprinting within hydrogels II: progress and analysis of the field.
    Byrne ME; Salian V
    Int J Pharm; 2008 Dec; 364(2):188-212. PubMed ID: 18824226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical structure modifications and nano-technology applications for improving ADME-Tox properties, a review.
    Farouk F; Shamma R
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800213. PubMed ID: 30609117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemistry strategies in early drug discovery: an overview of recent trends.
    Colombo M; Peretto I
    Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical product development technologies based on the biopharmaceutical classification system.
    Jain D; Pathak D; Pathak K
    Pharmazie; 2009 Aug; 64(8):483-90. PubMed ID: 19746834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microencapsulation by solvent evaporation: state of the art for process engineering approaches.
    Li M; Rouaud O; Poncelet D
    Int J Pharm; 2008 Nov; 363(1-2):26-39. PubMed ID: 18706988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
    Vistoli G; Pedretti A; Villa L; Testa B
    J Med Chem; 2005 Jul; 48(15):4947-52. PubMed ID: 16033273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Rule of Five revisited: applying log D in place of log P in drug-likeness filters.
    Bhal SK; Kassam K; Peirson IG; Pearl GM
    Mol Pharm; 2007; 4(4):556-60. PubMed ID: 17530776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Escape from flatland: increasing saturation as an approach to improving clinical success.
    Lovering F; Bikker J; Humblet C
    J Med Chem; 2009 Nov; 52(21):6752-6. PubMed ID: 19827778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Some common aspects of drug research, molecular recognition and information theory--new notion of chemical information.
    Borowiak MA
    Acta Pol Pharm; 1991; 48(3-4):75-81. PubMed ID: 1669545
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmaceutical cocrystals: an overview.
    Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
    Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On entropy-based molecular descriptors: statistical analysis of real and synthetic chemical structures.
    Dehmer M; Varmuza K; Borgert S; Emmert-Streib F
    J Chem Inf Model; 2009 Jul; 49(7):1655-63. PubMed ID: 19530677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
    Beaumont K; Smith DA
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems.
    Spyratou E; Mourelatou EA; Makropoulou M; Demetzos C
    Expert Opin Drug Deliv; 2009 Mar; 6(3):305-17. PubMed ID: 19327046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
    Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid form screening--a review.
    Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.